Market overview
The global ultrafiltration market is worth USD 6.4 bn in 2026 and is forecast to reach USD 15.7 bn by 2036, growing at a 9.5% CAGR. China is the largest country market and PVDF and PES polymeric is the largest by membrane material segment.
| Scope | Membranes and modules with pores of about 0.01 to 0.1 micron that remove particles, bacteria and large molecules, supplied for drinking and process water, food, dairy, dialysis and biopharma. |
|---|---|
| Industry | Healthcare |
| Value 2025 | USD 5.8 bn |
| Value 2026 | USD 6.4 bn |
| Value 2036 | USD 15.7 bn |
| CAGR 2026-2036 | 9.5% |
| Volume 2026 | 153 million square metres |
| Volume 2036 | 380 million square metres |
| Average price 2026 | USD 41.4 per square metre |
| Report price | Starts from USD 1,999 |
| Published | November 2026 |
Request a free sample of this report
Ultrafiltration market size and forecast, 2026-2036
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Year | Market value |
|---|---|
| 2026 | USD 6.4 bn |
| 2027 | USD 7.0 bn |
| 2028 | USD 7.6 bn |
| 2029 | USD 8.3 bn |
| 2030 | USD 9.1 bn |
| 2031 | USD 10.0 bn |
| 2032 | USD 10.9 bn |
| 2033 | USD 12.0 bn |
| 2034 | USD 13.1 bn |
| 2035 | USD 14.4 bn |
| 2036 | USD 15.7 bn |
Ultrafiltration market segmentation
By membrane material
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| PVDF and PES polymeric | 72.0% | 71.8% | USD 4.6 bn | 9.5% |
| Other polymeric | 16.0% | 13.9% | USD 1.0 bn | 8.0% |
| Ceramic | 12.0% | 14.3% | USD 762 mn | 11.5% |
By end use
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Water and wastewater | 58.0% | 56.4% | USD 3.7 bn | 9.2% |
| Biopharma | 18.0% | 21.9% | USD 1.1 bn | 11.7% |
| Food and beverage | 14.0% | 12.4% | USD 889 mn | 8.2% |
| Dialysis and medical | 10.0% | 9.3% | USD 635 mn | 8.7% |
By configuration
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Hollow fibre | 50.0% | 48.0% | USD 3.2 bn | 9.1% |
| Spiral wound | 20.0% | 20.0% | USD 1.3 bn | 9.5% |
| Flat sheet and cassette | 18.0% | 18.0% | USD 1.1 bn | 9.5% |
| Tubular | 12.0% | 14.0% | USD 762 mn | 11.2% |
By pore size
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Below 10 kDa | 22.0% | 20.0% | USD 1.4 bn | 8.5% |
| 10 to 100 kDa | 46.0% | 46.0% | USD 2.9 bn | 9.5% |
| Above 100 kDa | 32.0% | 34.0% | USD 2.0 bn | 10.2% |
By module
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Pressurised | 56.0% | 52.0% | USD 3.6 bn | 8.7% |
| Submerged | 28.0% | 30.0% | USD 1.8 bn | 10.3% |
| Skid-mounted | 16.0% | 18.0% | USD 1.0 bn | 10.8% |
Top 25 countries for ultrafiltration by revenue
Countries are ranked by revenue earned from sales in the country, not by where the product is made. The ten largest hold 85.0% of 2026 revenue and the 25 countries below together hold 95.5%.
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| # | Country | Value 2026 | Share 2026 | Value 2036 | CAGR 2026-36 |
|---|---|---|---|---|---|
| 1 | China | USD 1.9 bn | 30.0% | USD 5.7 bn | 11.6% |
| 2 | United States | USD 1.3 bn | 20.0% | USD 2.6 bn | 7.6% |
| 3 | Germany | USD 381 mn | 6.0% | USD 755 mn | 7.1% |
| 4 | Japan | USD 381 mn | 6.0% | USD 661 mn | 5.7% |
| 5 | India | USD 318 mn | 5.0% | USD 1.0 bn | 12.6% |
| 6 | Saudi Arabia | USD 254 mn | 4.0% | USD 693 mn | 10.6% |
| 7 | France | USD 254 mn | 4.0% | USD 504 mn | 7.1% |
| 8 | South Korea | USD 254 mn | 4.0% | USD 614 mn | 9.2% |
| 9 | Singapore | USD 191 mn | 3.0% | USD 472 mn | 9.5% |
| 10 | United Kingdom | USD 191 mn | 3.0% | USD 378 mn | 7.1% |
| 11 | Netherlands | USD 149 mn | 2.3% | USD 327 mn | 8.2% |
| 12 | Spain | USD 88 mn | 1.4% | USD 195 mn | 8.3% |
| 13 | Italy | USD 65 mn | 1.0% | USD 143 mn | 8.3% |
| 14 | Canada | USD 53 mn | 0.8% | USD 116 mn | 8.2% |
| 15 | Australia | USD 44 mn | 0.7% | USD 98 mn | 8.2% |
| 16 | Mexico | USD 39 mn | 0.6% | USD 121 mn | 12.1% |
| 17 | Russia | USD 34 mn | 0.5% | USD 76 mn | 8.2% |
| 18 | Turkey | USD 31 mn | 0.5% | USD 98 mn | 12.1% |
| 19 | Belgium | USD 29 mn | 0.5% | USD 63 mn | 8.2% |
| 20 | Egypt | USD 27 mn | 0.4% | USD 83 mn | 12.1% |
| 21 | Taiwan | USD 25 mn | 0.4% | USD 55 mn | 8.3% |
| 22 | Poland | USD 23 mn | 0.4% | USD 72 mn | 12.2% |
| 23 | Indonesia | USD 22 mn | 0.3% | USD 68 mn | 12.1% |
| 24 | Thailand | USD 20 mn | 0.3% | USD 65 mn | 12.2% |
| 25 | Israel | USD 20 mn | 0.3% | USD 61 mn | 12.0% |
| Rest of world | USD 285 mn | 4.5% | USD 641 mn | 8.4% |
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
Competitive landscape
Group 1: Global leaders
- DuPont
- Veolia
- Toray Industries
- Koch Separation Solutions
- Asahi Kasei
- Nitto Denko
- Xylem
Group 2: Regional and specialist players
- Pentair
- Pall Corporation
- Synder Filtration
- Mann+Hummel
- Alfa Laval
- Mitsubishi Chemical Group
- Hyflux
- Polymem
Group 3: Emerging and niche players
- Origin Water
- Hainan Litree Purifying Technology
- Suntar Membrane Technology
- Tianjin Motimo Membrane Technology
- Scinor Water
Research methodology
Every figure on this page comes from the research framework that we apply to all of the markets we cover. The 2025 base for the ultrafiltration market is built from the volume sold and the price that buyers pay, and is cross-checked against the size of the wider industry the market belongs to. Where a market can be sized in more than one way, the routes are compared before a figure is set.
The forecast runs year by year from the 2025 base to 2036. Growth in each year reflects demand from the industries that buy the product, adoption of new technology, pricing, regulation and replacement cycles. Volume and price are modelled together, so revenue in each year equals volume multiplied by average price. The 2026 to 2036 compound annual growth rate of 9.5% is calculated from the resulting values.
The market is divided by membrane material, by end use, by configuration, by pore size, by module. The 25 largest countries are ranked by revenue earned from sales to buyers in each country, not by where the product is made. Segment values and country values add up to the market total in every year, and every report is checked for consistency before it is published.
Companies are placed in three groups: global leaders, regional and specialist players, and emerging and niche players. The groups describe how companies compete in the market. They are not a ranking and they are not market shares.
Our analysts also carry out primary research. Customized reports add interviews with key opinion leaders, such as senior executives, technical specialists and buyers, to test the assumptions behind the numbers for the question being asked.
Frequently asked questions
How big is the ultrafiltration market?
The global ultrafiltration market is estimated at USD 5.8 bn in 2025 and USD 6.4 bn in 2026.
How fast will the ultrafiltration market grow?
It is forecast to reach USD 15.7 bn by 2036, a compound annual growth rate of 9.5% from 2026, an increase of USD 9.4 bn.
Which country is the largest market for ultrafiltration?
China is the largest market by revenue at USD 1.9 bn in 2026, 30.0% of the global total. The three largest countries together hold 56.0%.
Which country is growing fastest?
Among the ten largest markets, India is growing fastest at 12.6% a year from 2026 to 2036.
Which ultrafiltration segment is largest?
In the by membrane material split, PVDF and PES polymeric is the largest segment with 72.0% of 2026 revenue.
Who are the leading ultrafiltration companies?
Global leaders include DuPont, Veolia, Toray Industries, Koch Separation Solutions.
Need the full report?
Request a sample to see the structure, tables and country detail.
Request a free sampleRelated markets in Healthcare
- Fiber SupplementsUSD 6.4 bn · 6.5% CAGR
- Retail ClinicUSD 6.3 bn · 5.3% CAGR
- Good Manufacturing Practice ComplianceUSD 6.3 bn · 8.5% CAGR
- Single Use BioreactorUSD 6.2 bn · 12.0% CAGR
- Artificial Pancreas DeviceUSD 6.2 bn · 12.5% CAGR
- Mass SpectrometryUSD 6.6 bn · 7.0% CAGR
- Pen InjectorUSD 6.7 bn · 10.0% CAGR
- Tissue EngineeringUSD 6.0 bn · 10.5% CAGR